SCHEMBL7566334

SCHEMBL7566334

CCOC(=O)c1[nH]c2cccc(Cl)c2c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
KDM4E B2RXH2 6/20 0.48
HSD17B10 Q99714 3/20 0.48
ALDH1A1 P00352 5/20 0.48
HPGD P15428 4/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2C9 P11712 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HTR6 P50406 1/20 0.47
MAP3K5 Q99683 1/20 0.46
XBP1 P17861 1/20 0.46
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8794573 0.87 ALOX15 (0.51) MAPTMEN1KMT2AKDM4EHSD17B10
SCHEMBL19331202 0.85 NR4A2 (0.55) MEN1KMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL9449759 0.84 GPR17 (0.54) MAPTMEN1KMT2AKDM4EHSD17B10
SCHEMBL24074529 0.83 KDM4E (0.48) MAPTKMT2AKDM4EHSD17B10ALDH1A1
SCHEMBL6220087 0.83 ALOX15 (0.52) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL29813056 0.83 ALOX15 (0.52) MAPTKDM4EALDH1A1HPGDNPC1
SCHEMBL4139087 0.82 MAPT (0.51) MAPTMEN1KMT2AKDM4EHSD17B10
SCHEMBL15622537 0.82 MCL1 (0.53) MAPTMEN1KMT2AKDM4EHSD17B10
SCHEMBL8977641 0.82 ALDH1A1 (0.50) MAPTMEN1KMT2AKDM4EHSD17B10
SCHEMBL7834281 0.81 HTR6 (0.46) MAPTMEN1KMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885MEN1 3165/4885KMT2A 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.